0 CHECKOUT

Malaysia Pharmaceuticals and Healthcare Report Q4 2015

  • ID: 3389251
  • September 2015
  • Region: Malaysia
  • 133 pages
  • Business Monitor International
1 of 4

FEATURED COMPANIES

  • Bumimedic
  • GlaxoSmithKline
  • Kotra Pharma
  • Novartis
  • Pharmaniaga
  • Ranbaxy Malaysia
  • MORE

Malaysia's epidemiological profile will remain attractive to pharmaceutical companies as the country sees a rising burden of both communicable and non-communicable diseases. This commercial opportunity is further reinforced by the government's commitment to improve healthcare in its FY2015 budget. However, poor intellectual property protection and the implementation of a Goods and Service Tax continue dampen opportunities for innovative drugmakers.

Headline Expenditure Projections
- Pharmaceuticals: MYR7.22bn (USD2.21bn) in 2014 to MYR7.88bn (USD1.97bn) in 2015; +9.2% in local currency and -10.7% in US dollar terms. Forecast in line with last quarter.

- Healthcare: MYR42.62bn (USD13.02bn) in 2014 to MYR45.85bn (USD11.46bn) in 2015; +7.6% in local currency and -12.0% in US dollar terms. Forecast revised downwards from last quarter.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bumimedic
  • GlaxoSmithKline
  • Kotra Pharma
  • Novartis
  • Pharmaniaga
  • Ranbaxy Malaysia
  • MORE

SWOT

Political

Economic

Operational Risk

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Malaysia 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Malaysia 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Malaysia 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Malaysia 2011-2019)

Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Malaysia 2011-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Malaysia 2011-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Malaysia 2011-2019)

Malaysia
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Malaysia 2011-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Malaysia 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Malaysia 2013-2019)

Key Risks To Forecast Scenario

Macroeconomic Forecasts

Economic Analysis
Table: Economic Activity (Malaysia 2010-2019)

Industry Risk Reward Ratings

Asia Pacific Risk/Reward Index

Malaysia Risk/Reward Index

Rewards

Risks

Market Overview

Industry Trends And Developments

Epidemiology

Healthcare Sector
Table: 2011 Entry Point Projects Summary
Table: Healthcare Resources (Malaysia 2009-2014)
Table: Healthcare Personnel (Malaysia 2009-2014)
Table: Healthcare Activity (Malaysia 2009-2014)

Healthcare Insurance
Table: Main Features Of 1Care

Healthcare Funding

Healthcare Sector Developments
Table: Public Sector And Private Sector Healthcare Developments

Medical Tourism

Research & Development

Clinical Trials

Regulatory Development

Regulatory Regime
Table: Drug Applications by Type, 2002-2010
Table: Registered Pharmaceutical Products by Type, 2002-10

Regulatory Developments

Intellectual Property Issues

Pricing Regime

Competitive Landscape

Domestic Industry

Foreign Industry
Table: Leading Malaysian Pharmaceutical And Healthcare Companies

Culture-Specific Medicines

Pharmaceutical Distribution
Table: Drug Wholesalers & Importers, 2002-2010

Pharmaceutical Retail Sector

Company Profile

Bumimedic

Chemical Company Of Malaysia

Eli Lilly Malaysia

GlaxoSmithKline

Hovid

Kotra Pharma

Merck & Co

Novartis

Pfizer

Pharmaniaga

Prime Pharmaceutical

Ranbaxy Malaysia

Sanofi

Demographic Forecast
Table: Population Headline Indicators (Malaysia 1990-2025)
Table: Key Population Ratios (Malaysia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Malaysia 1990-2025)
Table: Population By Age Group (Malaysia 1990-2025)
Table: Population By Age Group % (Malaysia 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

Bumimedic
Chemical Company Of Malaysia
Eli Lilly Malaysia
GlaxoSmithKline
Hovid
Kotra Pharma
Merck & Co
Novartis
Pfizer
Pharmaniaga
Prime Pharmaceutical
Ranbaxy Malaysia
Sanofi

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Pfizer Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S